Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Link
http://www.springerlink.com/index/pdf/10.1007/s10637-011-9655-z
Reference52 articles.
1. Spitz IM (2006) Progesterone receptor antagonists. Curr Opin Investig Drugs 7(10):882–890
2. Benagiano G, Bastianelli C, Farris M (2008) Selective progesterone receptor modulators 1: use during pregnancy. Expert Opin Pharmacother 9(14):2459–2472. doi: 10.1517/14656566.9.14.2459
3. Benagiano G, Bastianelli C, Farris M (2008) Selective progesterone receptor modulators 2: use in reproductive medicine. Expert Opin Pharmacother 9(14):2473–2485. doi: 10.1517/14656566.9.14.2473
4. Moller C, Hoffmann J, Kirkland TA, Schwede W (2008) Investigational developments for the treatment of progesterone-dependent diseases. Expert Opin Investig Drugs 17(4):469–479. doi: 10.1517/13543784.17.4.469
5. Li D-Q, Wang Z-B, Bai J, Zhao J, Wang Y, Hu K, Du Y-H (2004) Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7901 in vitro. World J Gastroenterol 10(18):2628–2631
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone;Cancer Cell International;2022-12-09
2. CmPn signaling networks in the tumorigenesis of breast cancer;Frontiers in Endocrinology;2022-09-29
3. CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling;Cell Communication and Signaling;2022-08-15
4. CmP signaling network unveils novel biomarkers for triple negative breast cancer in African American women;Cancer Biomarkers;2022-07-18
5. Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies;Journal of Neurosurgical Sciences;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3